BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination Genzyme Corp That Certain Collaboration And License Agreement

Reuters

05-09

BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination Genzyme Corp That Certain Collaboration And License Agreement

IGM Biosciences Inc IGMS.O:

IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENT
IGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCE
IGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASH
IGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONS

Source text: [ID:n0001193125-25-116071]

Further company coverage: IGMS.O

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2534446193"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2534446193\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2534446193?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-09 06:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534446193","market":"nz","top_or_hot":-1,"title":"BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement</title></head><body><p><a href=\"https://laohu8.com/S/IGMS\">IGM Biosciences</a> Inc <span>IGMS.O</span>:</p><ul><li><p>IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENT</p></li><li><p>IGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCE</p></li><li><p>IGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASH</p></li><li><p>IGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONS</p></li></ul><p>Source text: [ID:n0001193125-25-116071]</p><p>Further company coverage: <span>IGMS.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-09 06:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License Agreement</title></head><body><p><a href=\"https://laohu8.com/S/IGMS\">IGM Biosciences</a> Inc <span>IGMS.O</span>:</p><ul><li><p>IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENT</p></li><li><p>IGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCE</p></li><li><p>IGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASH</p></li><li><p>IGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONS</p></li></ul><p>Source text: [ID:n0001193125-25-116071]</p><p>Further company coverage: <span>IGMS.O</span></p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4505","symbol_name":"高瓴資本持倉","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG4U5:1","article_id":"2534446193","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534446193","pubTimestamp":1746743087,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License AgreementIGM Biosciences Inc IGMS.O:IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENTIGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCEIGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASHIGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONSSource text: [ID:n0001193125-25-116071]Further company coverage: IGMS.O","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4505":"高瓴资本持仓","IGMS":"IGM Biosciences","BK4139":"生物科技"},"translate_title":"简介-Igm Biosciences Inc表示，5月5日，Co收到Genzyme Corp终止某些合作和许可协议的通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IGMS":0.9},"content_text":"BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination  Genzyme Corp That Certain Collaboration And License AgreementIGM Biosciences Inc IGMS.O:IGM BIOSCIENCES INC SAYS ON MAY 5, CO RECEIVED NOTICE OF TERMINATION  GENZYME CORP THAT CERTAIN COLLABORATION AND LICENSE AGREEMENTIGM BIOSCIENCES - IN CONNECTION WITH AGREEMENT TERMINATION, CO IMPLEMENTED ABOUT 80% REDUCTION IN REMAINING WORKFORCEIGM BIOSCIENCES INC SAYS CLOSED MOST OF REMAINING LAB AND OFFICE FACILITIES TO PRESERVE CASHIGM BIOSCIENCES INC SAYS CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES AND REORGANIZATION OPTIONSSource text: [ID:n0001193125-25-116071]Further company coverage: IGMS.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"corporation,event","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}